- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT04229056
Tietokoneavusteinen itsekoulutus executive-toimintojen parantamiseksi (COMPEX)
Computer-Assisted Self-Training to Improve Executive Function Versus Unspecific Training in Patients After Stroke, Cardiac Arrest or in Parkinson's Disease: A Randomized Controlled Trial
This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to generally cognitively stimulating activities on a computer
Tutkimuksen yleiskatsaus
Tila
Ehdot
Yksityiskohtainen kuvaus
This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to completing generally cognitively stimulating activities on a computer. A total of 307 patients is expected to be enrolled. All patients will complete a neuropsychological test battery assessing executive functions at inclusion, directly after the eight-week training period and at follow-up three months after the end of the intervention period. Furthermore, all patients will answer questionnaires concerning quality of life and ADL-measures at baseline, after the intervention and at follow-up. All patients will train for a period of 8 weeks, 5 times a week for 60 minutes regardless of their group allocation.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
-
Copenhagen, Tanska
- Rigshospitalet
-
Copenhagen, Tanska
- Bispebjerg Hospital
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- A diagnose of stroke, cardiac arrest or Parkinson's disease.
- Aged 18 years or older.
- Impaired working memory measured with CABPad working memory test, cut off for inclusion: 5 symbols or less backwards
- Computer and internet access at home.
- Providing informed consent.
Inclusion criteria specific for stroke
- Inclusion within 6 months post-stroke
- Stroke confirmed by clinical findings and imaging, both AIS and ICH is allowed.
- Initial stroke severity >/= NIHSS 3.
Inclusion criteria specific for cardiac arrest
• Inclusion within 6 months post ictus.
Inclusion criteria specific for Parkinson's disease
- Clinical diagnosis of PD.
- Anti-parkinsonian medical treatment (dopaminergic or other).
Exclusion Criteria:
- Informed consent not provided
- Other neurological or psychiatric disease which is expected to influence the patient's ability to participate in the trial according to the investigator
- Not able to participate according to investigator
Exclusion criteria specific for stroke
- Patients with massive anosognosia for executive dysfunction or patients with no subjective feeling of executive dysfunction (Patient sustains total denial of executive symptoms over time)
- Patients with severe aphasia, in which it is unclear whether the patient's performance on a neuropsychological test-battery is due to aphasia and not executive dysfunction.
Exclusion criteria specific for cardiac arrest • None
Exclusion criteria specific for PD
• Diagnosis of PD Dementia according to the MDS PD Dementia criteria
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Specific computer-based cognitive rehabilitation
154 patients will be allocated to specific computer-based cognitive rehabilitation. This group will train with 10 exercises from the cognitive rehabilitation software 'Scientific Brain training PRO'. These 10 exercises are designed to train various executive functions. |
CBCR are software-programmes for computers which are clinically developed for rehabilitation of various cognitive functions. |
|
Active Comparator: General computer-based cognitive stimulation
154 patients will be allocated to general computer-based cognitive stimulation. This group will train with 10 generally mentally stimulating games on a website specifically designed for this trial. These 10 games are chosen because they are believed to have a low load on executive functions but stimulate over-all concentration and visuoperceptual abilities. |
For this trial we have developed a webpage for general cognitive stimulation, which is designed to provide general computer-based cognitive stimulation. |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
CABPad Working Memory Test
Aikaikkuna: After the end of the intervention (8 weeks after baseline)
|
Test of working memory. The higher score the better (theoretically infinite score) |
After the end of the intervention (8 weeks after baseline)
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
CABPad Working Memory Test - 3 months follow-up
Aikaikkuna: At follow-up visit 3 months after end of intervention
|
Test of working memory. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after end of intervention
|
|
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Aikaikkuna: At follow-up visit 3 months after the end of the intervention
|
Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better. |
At follow-up visit 3 months after the end of the intervention
|
|
Trail Making A
Aikaikkuna: Directly after the intervention, eight weeks after inclusion
|
Test of processing speed and visual attention. The lower score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Trail Making A
Aikaikkuna: At follow-up visit 3 months after the end of the intervention
|
Test of processing speed and visual attention. The lower score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Trail Making B
Aikaikkuna: Directly after the intervention, eight weeks after inclusion
|
Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Trail Making B
Aikaikkuna: At follow-up visit 3 months after the end of the intervention
|
Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
SDMT
Aikaikkuna: Directly after the intervention, eight weeks after inclusion
|
Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
SDMT
Aikaikkuna: At follow-up visit 3 months after the end of the intervention
|
Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Phonological verbal fluency test
Aikaikkuna: Directly after the intervention, eight weeks after inclusion
|
Test of verbal phonological fluency. The higher score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Phonological verbal fluency test
Aikaikkuna: At follow-up visit 3 months after the end of the intervention
|
Test of verbal phonological fluency. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Categorical verbal fluency test
Aikaikkuna: Directly after the intervention, eight weeks after inclusion
|
Test of verbal categorical fluency. The higher score the better (theoretically infinite score) |
Directly after the intervention, eight weeks after inclusion
|
|
Categorical verbal fluency test
Aikaikkuna: At follow-up visit 3 months after the end of the intervention
|
Test of verbal categorical fluency. The higher score the better (theoretically infinite score) |
At follow-up visit 3 months after the end of the intervention
|
|
Fear questionnaire
Aikaikkuna: Directly after the intervention, eight weeks after inclusion
|
Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear |
Directly after the intervention, eight weeks after inclusion
|
|
Fear questionnaire
Aikaikkuna: At follow-up visit 3 months after the end of the intervention
|
Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear |
At follow-up visit 3 months after the end of the intervention
|
|
mrs: Modified Rankin Scale
Aikaikkuna: Directly after the intervention, eight weeks after inclusion
|
Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead): Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
mrs: Modified Rankin Scale
Aikaikkuna: At follow-up visit 3 months after the end of the intervention
|
Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Aikaikkuna: Directly after the intervention, eight weeks after inclusion
|
Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Aikaikkuna: At follow-up visit 3 months after the end of the intervention
|
Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
EuroQol-5 domain (EQ-5D-5L)
Aikaikkuna: Directly after the intervention, eight weeks after inclusion
|
Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability . Higher score indicates more severe disability. Completed by patient and partner |
Directly after the intervention, eight weeks after inclusion
|
|
EuroQol-5 domain (EQ-5D-5L)
Aikaikkuna: At follow-up visit 3 months after the end of the intervention
|
Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability. Higher score indicates more severe disability. Completed by patient and partner |
At follow-up visit 3 months after the end of the intervention
|
|
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinson Disease)
Aikaikkuna: Directly after the intervention, eight weeks after inclusion
|
Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinsons Disease)
Aikaikkuna: At follow-up visit 3 months after the end of the intervention
|
Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
Compliance
Aikaikkuna: Directly after the intervention, eight weeks after inclusion
|
Monitoring of total time spent training in minutes |
Directly after the intervention, eight weeks after inclusion
|
|
PHQ-9 (Patient health questionnaire 9)
Aikaikkuna: Directly after the intervention, eight weeks after inclusion
|
Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability. |
Directly after the intervention, eight weeks after inclusion
|
|
PHQ-9 (Patient health questionnaire 9)
Aikaikkuna: At follow-up visit 3 months after the end of the intervention
|
Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability. |
At follow-up visit 3 months after the end of the intervention
|
|
2) visual analogue scale (1-10)
Aikaikkuna: Directly after the intervention, eight weeks after inclusion
|
After last session: how much they liked doing the training and if they would recommend the intervention to somebody else in their situation. Higher score indicates they liked the training more. |
Directly after the intervention, eight weeks after inclusion
|
|
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Aikaikkuna: Directly after the intervention, eight weeks after inclusion
|
Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better. |
Directly after the intervention, eight weeks after inclusion
|
Yhteistyökumppanit ja tutkijat
Sponsori
Yhteistyökumppanit
Tutkijat
- Päätutkija: Hanne Christensen, Professor, Bispebjerg Hospital
Julkaisuja ja hyödyllisiä linkkejä
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
- Synukleinopatiat
- Aivoverenkiertohäiriöt
- Aivojen sairaudet
- Keskushermoston sairaudet
- Hermoston sairaudet
- Verisuonisairaudet
- Sydän-ja verisuonitaudit
- Mielenterveyshäiriöt
- Sydänsairaudet
- Neurokognitiiviset häiriöt
- Kognitiohäiriöt
- Neurodegeneratiiviset sairaudet
- Liikkumishäiriöt
- Parkinsonin häiriöt
- Basal ganglia -taudit
- Aivohalvaus
- Kognitiivinen toimintahäiriö
- Sydänpysähdys
- Parkinsonin tauti
Muut tutkimustunnusnumerot
- H-19039236
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
This is currently undecided
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .